Business
The New York-based company also reported a 110% increase in fourth-quarter revenue in 2024 compared to Q4 2023 and a Q4 2024 net loss of $9.6 million.
Upcoming features include pre-chart summary creation.
The panelists highlighted digital health investments, innovation, interoperability and integration.
HIMSS25
Healthcare leaders and clinical informaticists can help decide which digital tools are most useful and accessible for patients without being overwhelming, says Whende Carroll, clinical informatics advisor at HIMSS.
Dr. Min-Che Tung, chief superintendent at Tungs' Taichung MetroHarbor Hospital, discusses the country's international medical transfer services for critical care patients and how the health system accomplished Stage 7 EMRAM validation.
HIMSS25
Successful documentation improvements require collaboration and frontline nurses to be engaged in the decision-making process to drive change and meaningful improvement, says NYU Langone Health's Denise Dauterman and Deborah Jacques.
The New York-based company posted a net loss of $1 billion, or $5.87 per share, causing its stock price to fall around 15%.
AI tools helped find non-opioid pain medications that can also put patients under and predict strokes in children who have undergone brain surgery, says Dr. Zafar Chaudry, chief AI officer at Seattle Children's.
Before the technology piece, focus must be on how to train people on the up-and-coming AI tools and providing a policy that governs those tools and protecting data, says Dr. Zafar Chaudry, chief AI officer at Seattle Children's.
HIMSS25
At HIMSS25, Tamer Baker, healthcare CTO for Zscaler, and Nate Couture, CISO for the University of Vermont Health Network, will discuss zero trust's strategy and how critical it is to facilitate breach recovery and prevention after an attack.